Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution.

CLL SARS-CoV-2 persistent infection viral evolution

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 06 04 2021
accepted: 03 06 2021
entrez: 14 7 2021
pubmed: 15 7 2021
medline: 15 7 2021
Statut: epublish

Résumé

We report a coronavirus disease 2019 case with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) persisting beyond 333 days in an immunocompromised patient with chronic lymphocytic leukemia, asymptomatically carrying infectious SARS-CoV-2 at day 197 postdiagnosis. In addition, viral sequencing indicates major changes in the spike protein over time, temporally associated with convalescent plasma treatment.

Identifiants

pubmed: 34258320
doi: 10.1093/ofid/ofab295
pii: ofab295
pmc: PMC8244814
doi:

Types de publication

Journal Article

Langues

eng

Pagination

ofab295

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Références

EBioMedicine. 2021 Feb;64:103230
pubmed: 33530000
Cell. 2020 Oct 1;183(1):158-168.e14
pubmed: 32979941
Nat Med. 2021 Apr;27(4):622-625
pubmed: 33654292
Curr Hematol Malig Rep. 2012 Mar;7(1):13-20
pubmed: 22231031
J Clin Virol. 2020 Aug;129:104468
pubmed: 32485620
Cell. 2020 Dec 23;183(7):1901-1912.e9
pubmed: 33248470
Cell Rep. 2021 Jun 29;35(13):109292
pubmed: 34166617
Nature. 2020 Aug;584(7819):115-119
pubmed: 32454513
EBioMedicine. 2021 Jun;68:103410
pubmed: 34098342
Blood. 2015 Jul 30;126(5):573-81
pubmed: 26084672
Nature. 2021 Apr;592(7853):277-282
pubmed: 33545711
Elife. 2020 Oct 28;9:
pubmed: 33112236
Nature. 2020 Aug;584(7821):457-462
pubmed: 32668444
Blood. 2020 Nov 12;136(20):2290-2295
pubmed: 32959052
Int J Mol Sci. 2020 Mar 06;21(5):
pubmed: 32155826
N Engl J Med. 2020 Dec 3;383(23):2291-2293
pubmed: 33176080
Nature. 2021 May;593(7857):130-135
pubmed: 33684923
Science. 2021 Mar 12;371(6534):1139-1142
pubmed: 33536258
Cell. 2021 Apr 29;184(9):2332-2347.e16
pubmed: 33761326

Auteurs

Ida Monrad (I)

Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Signe Risgaard Sahlertz (SR)

Department of Medicine, Regional Hospital West Jutland, Herning, Denmark.

Stine Sofie Frank Nielsen (SSF)

Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Louise Ørnskov Pedersen (LØ)

Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.

Mikkel Steen Petersen (MS)

Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.

Carl Mathias Kobel (CM)

Department of Clinical Microbiology, Aarhus University Hospital, Aarhus, Denmark.

Irene Harder Tarpgaard (IH)

Department of Clinical Microbiology, Aarhus University Hospital, Aarhus, Denmark.

Merete Storgaard (M)

Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.

Klaus Leth Mortensen (KL)

Department of Medicine, Regional Hospital West Jutland, Herning, Denmark.

Mariane H Schleimann (MH)

Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.

Martin Tolstrup (M)

Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Line K Vibholm (LK)

Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.

Classifications MeSH